CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administration
{{output}}
Tacrolimus is prescribed to the majority of transplant recipients to prevent graft rejection, and although patients are maintained on oral administration, nonoral routes of administration are frequently used in the initial post-transplant period. CYP3A5 genoty... ...
